A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis

BACKGROUND: REFINE was an exploratory, dose- and frequency-blinded, prospective, randomized, dose-ranging study in relapsing–remitting multiple sclerosis (RRMS) patients. OBJECTIVE: To examine the efficacy, safety, and tolerability of natalizumab administered via various regimens in RRMS patients. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Trojano, Maria, Ramió-Torrentà, Lluís, Grimaldi, Luigi ME, Lubetzki, Catherine, Schippling, Sven, Evans, Karleyton C, Ren, Zheng, Muralidharan, Kumar Kandadi, Licata, Stephanie, Gafson, Arie R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597184/
https://www.ncbi.nlm.nih.gov/pubmed/33821693
http://dx.doi.org/10.1177/13524585211003020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8597184/
https://www.ncbi.nlm.nih.gov/pubmed/33821693
http://dx.doi.org/10.1177/13524585211003020

Ejemplares similares